Skip to content
Screener

PP&E (Net) at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$155.13M+38.6%
ALN
Alnylam PharmaceuticalsALNY
$554.14M+10.9%
Assembly Biosciences logo
Assembly BiosciencesASMB
$214K-14.7%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$22K-86.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$235M-8.1%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$101.25M-7.6%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Prepaid expenses21,72110,933
Other current assets18,25413,516
Total current assets1,839,751950,639
Property, plant and equipment, net374,822382,515
Intangible assets, net6,0116,861
Right-of-use assets42,79443,891
Other assets4,8871,389
Total Assets$2,268,265$1,385,295

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's PP&E (net)?
Arrowhead Research (ARWR) reported PP&E (net) of $374.82M in Q1 2026.
How has Arrowhead Research's PP&E (net) changed year-over-year?
Arrowhead Research's PP&E (net) decreased by 2.6% year-over-year, from $384.8M to $374.82M.
What is the long-term trend for Arrowhead Research's PP&E (net)?
Over 4 years (2021 to 2025), Arrowhead Research's PP&E (net) has grown at a 67.4% compound annual growth rate (CAGR), from $48.68M to $382.52M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Arrowhead Research's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude